Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable

Indian Journal of Medical Research

Volumn 123, Issue 3, 2006, Pages 195-196

  Bhattacharya, Sujit K ^a   Sur, Dipika ^b   Sinha, P K ^a   Karbwang, Juntra ^c  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY; MILTEFOSINE;

BANGLADESH; DEATH; DIAGNOSTIC TEST; DRUG COST; EDITORIAL; ENDEMIC DISEASE; FEASIBILITY STUDY; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS; MALARIA; MEDICAL RECORD; MORBIDITY; MORTALITY; NEPAL; NONHUMAN; PARASITE INCIDENCE; PARASITE PREVALENCE; PARASITE VECTOR; POPULATION RESEARCH; POVERTY; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; SUPERINFECTION; TREATMENT PLANNING;

ANTIPROTOZOAL AGENTS; COMMUNICABLE DISEASE CONTROL; HIV INFECTIONS; HUMANS; INDIA; LEISHMANIASIS, VISCERAL; PUBLIC HEALTH;

EID: 33745190020     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Life in the twenty-first century: a vision for all. The World Health Report 1998. Geneva: World Health Organization; 1998 p. 45.
2. Desjeux P. Human leishmaniases: Epidemiology and public health aspects. World Health Stat Q 1992; 45: 267-75.
3. Sinha PK, Das VN, Pandey K, Verma N, Gupta AK, Ranjan A, et al. Visceral leishmaniasis and HIV co-infection in Bihar, India. J Acquir Immune Defic Syndr 2003; 32: 115-6.
4. Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Trans R Soc Trop Med Hyg 2000; 94: 696-7.
5. Murray CJL, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994; 72: 495-509.
6. Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, et al. Factors associated with visceral leishmaniasis in Nepal: bed net use is strongly protective. Am J Trop Med Hyg 2000; 63: 184-8.
7. Sunder S, Reed SG, Singh VP, Kumar PCK, Murray HW. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 1998; 351: 563-5.
8. Sunder S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002; 347: 1739-46.
9. Bhattacharya SK, Jha TK, Sunder S, Thakur CP, Engel J, Sindermann H, et al. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 2004; 38: 217-21.